-
A Phase 3 Multi-Center Randomized Double-Blind Trial to Evaluate The Efficacy and Safety of Aficamten Compared To Placebo in Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
The purpose of this research study is to compare the effects of aficamten and placebo on health status and exercise capacity in participants with non-obstructive ...